NAD+: The Mitochondrial and Longevity Research Guide

NAD+ (nicotinamide adenine dinucleotide) is not a peptide — it is a small-molecule coenzyme — but it sits at the centre of longevity research and is routinely shipped, reconstituted, and dosed using the same workflow as injectable peptides. It is one of the most studied targets in cellular-aging literature.

What NAD+ does

NAD+ is the obligate electron carrier in mitochondrial ATP production. It also serves as the required substrate for two major enzyme families:

• Sirtuins (SIRT1–7) — NAD+-dependent deacetylases that regulate gene expression, DNA repair, mitochondrial biogenesis, and metabolic switching
• PARPs (poly-ADP-ribose polymerases) — DNA damage repair enzymes that consume NAD+ during chromatin remodelling
• CD38 — an immune-cell NAD+ hydrolase that increases sharply with age and accelerates NAD+ depletion

When NAD+ levels fall, all three of these systems lose substrate at once. Sirtuins slow, DNA repair becomes less efficient, and mitochondrial biogenesis declines.

Why NAD+ declines with age

Published research describes a 40–60% drop in tissue NAD+ between ages 20 and 60. The drivers are multifactorial:

• Increased CD38 expression in aged immune cells (faster hydrolysis)
• Reduced expression of NAMPT, the rate-limiting enzyme in NAD+ salvage
• Chronic low-grade inflammation that activates PARPs and depletes NAD+
• Reduced precursor availability (niacin, tryptophan) in many modern diets

The NAD+ decline is one of the most reproducible biochemical markers of biological aging, which is why restoring it is a focal point in longevity research.

Research findings

Published research on NAD+ restoration and its precursors (NMN, NR) describes:

• Improved mitochondrial respiration in aged tissue
• Restored sirtuin activity, particularly SIRT1 and SIRT3
• Improved insulin sensitivity in age-related models
• Enhanced endothelial function and vascular elasticity
• Improved physical endurance in animal aging studies
• Cognitive performance improvements in some clinical research arms

Research comparing direct NAD+ administration with its precursors (NMN, NR) is ongoing — each route has trade-offs in bioavailability, conversion efficiency, and cost.

Direct NAD+ vs precursors

Three main approaches appear in longevity research:

Approach	Mechanism	Trade-off
Direct NAD+	Restores the molecule itself	Lower bioavailability orally; subQ or IV preferred
NMN	One-step precursor	Excellent oral bioavailability in research; widely studied
NR	Two-step precursor	First commercial precursor, lower direct potency

For research applications targeting rapid tissue restoration, direct NAD+ administration is the most common route. For long-arc studies, NMN and NR appear more often because of oral convenience.

Common research dose ranges

Reported research ranges in the literature:

• Subcutaneous NAD+: 100–500 mg per dose, 2–3 times per week
• Intravenous NAD+: 250–1,000 mg per infusion, 1–2 times per week
• Maintenance protocols: 100–250 mg subcutaneously, 1–2 times per week

Loading phases of 4–6 weeks at the upper end are common in research, followed by maintenance dosing.

Dose figures above are reference figures observed in published longevity and metabolic research literature. They are not medical advice or recommendations for human use.

Reconstitution from a 500 mg vial

NAD+ ships lyophilized and is reconstituted with bacteriostatic water. A 500 mg vial reconstituted with 2 mL BAC water gives 250 mg/mL. A 250 mg dose is 1 mL, or 100 units on a U-100 insulin syringe.

Reconstituted NAD+ is light- and heat-sensitive. Store refrigerated at 2–8 °C and protect from light. Research stability references describe a 4–6 week window. The solution should remain colourless to pale yellow — a brown tint suggests oxidation and the vial should be discarded.

Stacking notes

NAD+ pairs naturally with Epithalon in longevity research protocols — Epithalon targets telomere biology via pineal-axis signalling while NAD+ targets mitochondrial and sirtuin pathways. The two operate on different aging mechanisms and do not overlap.

Use the ZORVYN Dose Calculator to verify reconstitution math for any vial size and BAC water volume.